(Date:11/9/2009)... Doctor house calls now a...cian. , New York, NY (PRW...nagement physician, will now offer routine house c...atients will be able to request a house call by ...mail from davisbregman.com . The convenience of b...
(Date:11/9/2009)... Leading U.S. air ambulan...th CAMTS and EURAMI accreditation and Department o...mingham, AL (PRWEB) November 9, 2009 -- AirMed Int..., announced today it has earned full accreditation.... EURAMI is a Stuttgart, Germany, based non-profi...
(Date:11/9/2009)...,, NEW YORK, Nov. 9 Davis Bre... routine house calls to residents of Manhattan in ... house call by calling the office at 212-918-1... The convenience of being able to see the doctor ...regman to try this new way of seeing most patients...
(Date:11/8/2009)...,, WASHINGTON, Nov. 8 /PRNewswire-USNewswire/ -...issued the following statement about the passage o...us and the American voters a lot about core values... core values, seeking to overcome the struggles or...ggles mean that many cannot afford basic healthcar...
(Date:11/8/2009)... UCW Academy of Health ho... Victoria, BC (Vocus) November 8, 2009 -...start a career in British Columbia’s health ...ia on Wednesday, November 25, 2009. , ,UCW Academ...s administration, nursing and social services, des...
Breaking Medicine News(10 mins):Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2...ears have seen the rapid emergence of minimally in...owever, the training of surgeons in this field sti... Chmarra has changed this state of affairs by deve...hmark for measuring a surgeon,s basic skills in th...
..., Ill., Jan. 12 /PRNewswire/ - - A new report sho... of dentists in the nation, a position the nation,...than five decades. The report by NetMinder, an ind...han 123,000 dentists, totaling more than 62,000 de...
...ASHINGTON, Jan. 12 Sharing Miracles, a 30-minute ...ompelling and inspirational stories of real patien... www.SharingMiracles.com . Sharing Miracles also ...inee and former star of Family Ties Meredith Baxte...
... S.C., Jan. 12 Half of working Americans with h...ar understanding of what their health insurance co...ent. According to a recent nationwide survey of 1,...*: , , , 51 percent of employees surveye...
...NNATI, Jan. 12 Kendle (Nasdaq: KNDL ) a,leading...on, today announced,revised financial expectations....newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO ) ...$485,million to $500 million, primarily due to the...
...and SAN FRANCISCO, Jan. 12 WeissComm Group, the p...ndependent communications agency focused exclusive...unications, an agency focused on helping companies...ompanies to cultivate unique brands that resonate ...
Other Medicine News:Health News:New training method helps surgeons evaluate their own minimally invasive surgery skills 2Health News:New Data Show Delta Dental Continues Offering Largest Nationwide Network 2Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 2Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 3Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 4Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 5Health News:'Sharing Miracles' Television Program Now Reaches Worldwide Audience 6Health News:Half of Full-Time Employees Surveyed Don't Understand Health Insurance Coverage for Cancer-Related Medical Expenses 2Health News:Half of Full-Time Employees Surveyed Don't Understand Health Insurance Coverage for Cancer-Related Medical Expenses 3Health News:Half of Full-Time Employees Surveyed Don't Understand Health Insurance Coverage for Cancer-Related Medical Expenses 4Health News:Kendle Revises Full Year 2008 Guidance 2Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 2Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 3(Date:11/6/2009)...SAN DIEGO, Nov. 6 NexBio Inc., in ...isease Control and Prevention (CDC), St. Louis Uni...d today the publication of two articles in the pee...studies suggest that DAS181 (Fludase ® ) may ...t and prevention of the Pandemic Influenza A(H1N1)...
(Date:11/6/2009)... PARIS, November 6 , -... Linezolid for the,Treatment of Multi-Resistant St...ovexel, a speciality pharmaceutical company focuse...otics designed to overcome the significant global,...hat its most advanced oral,antibacterial NXL103 (f...
(Date:11/5/2009)...POINT RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCa...SPT ), a specialty pharmaceutical company focused ...etary products that address important therapeutic ...d it will host a webcast and teleconference with m...results on Thursday, November 12, 2009, at 5:00 p....
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8Antigen Discovery Inc Awarded Grant for Chlamydia Vaccine Development 14163 1Antigen Discovery Inc Awarded Grant for Chlamydia Vaccine Development 14163 2Life Science Firms are Turning to Firmex to do Deals Online 14161 1Life Science Firms are Turning to Firmex to do Deals Online 14161 2Life Science Firms are Turning to Firmex to do Deals Online 14161 3... PCOP ), an innovator in the discovery and develo...announced that Schering-Plough has,initiated a Pha...8115, a,compound identified from the collaboration...evaluated as a potential treatment for respiratory...ilestone payment from,Schering-Plough as a result ...
...Phase -, WALTHAM, Mass., Sept. 25 Arbios Systems...its clinical trial strategy for,the SEPET(TM) Live...pre-pivotal phase meeting with the US Food and Dru...Arbios and the FDA,s Office for Device Evaluation,...g receipt of a final,report, SEPET(TM) has met the...
Other Medicine Technology:Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 2Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 3Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 4Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial 2Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial 3Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial 4Human Cardiac-Specific Troponin-I Enzyme Immunoassay (cTnI ELISA)
Acute Care Cardiac Troponin I
... brings true automation and continuous random acce...y sensitive assays for thyroid, anemia, cardiac, r...bolism testing are currently available, with infec... ECi can simultaneously process 60 accessible samp...
Myoglobin Test Modules
Medicine Products: